Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Lilja
    Lilja
  2. Hakimi
    Hakimi
  3. Vickers
    Vickers
  4. Coleman
    Coleman
  5. Schultz
    Schultz
  6. Solit
    Solit
  7. Abida
    Abida
  8. Berger
    Berger
  9. Carlsson
    Carlsson
  10. Eastham
    Eastham

Groups

  1. Sloan Kettering Institute Postdocs (31)
  2. Surgery (18)
  3. Urology (18)
  4. Epidemiology and Biostatistics (16)
  5. Population Sciences Research Program (11)
  6. Survivorship Research (11)
  7. Department of Medicine (10)
  8. GSK Faculty (10)
  9. Genitourinary Oncology Service (10)
  10. Solid Tumor Oncology Division (10)
Search Within
  1. "Sloan Kettering Institute Postdocs"
  2. "European Urology"
Formats
  1. Journal Article (22)
  2. Editorial (3)
  3. Meeting Abstract (2)
  4. Research Letter (2)
  5. Correspondence (1)
  6. Review (1)
Groups
  1. Sloan Kettering Institute Postdocs (31)
  2. Surgery (18)
  3. Urology (18)
  4. Epidemiology and Biostatistics (16)
  5. Population Sciences Research Program (11)
  6. Survivorship Research (11)

More Groups

People
  1. Konrad Stopsack (8)
  2. Hans David Ulmert (7)
  3. Hans Lilja (7)
  4. Abraham Hakimi (5)
  5. Andrew Vickers (5)
  6. Michael Zelefsky (5)

More People

Years
  1. 2023 (3)
  2. 2022 (2)
  3. 2021 (5)
  4. 2020 (2)
  5. 2019 (3)
  6. 2018 (4)

More Years

Publications
  1. European Urology (31)

Results (31)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • 2022 Update on Prostate Cancer Epidemiology and Risk Factors-A systematic review
    Review

    Bergengren, O.; Pekala, K. R.; Matsoukas, K.; Fainberg, J.; Mungovan, S. F.; Bratt, O.; Bray, F.; Brawley, O.; Luckenbaugh, A. N.; Mucci, L.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • A healthy lifestyle in men at increased genetic risk for prostate cancer
    Journal Article

    Plym, A.; Zhang, Y.; Stopsack, K. H.; Delcoigne, B.; Wiklund, F.; Haiman, C.; Kenfield, S. A.; Kibel, A. S.; Giovannucci, E.; Penney, K. L.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Analysis of BRCA2 copy number loss and genomic instability in circulating tumor cells from patients with metastatic castration-resistant prostate cancer
    Journal Article

    Barnett, E. S.; Schultz, N.; Stopsack, K. H.; Lam, E. T.; Arfe, A.; Lee, J.; Zhao, J. L.; Schonhoft, J. D.; Carbone, E. A.; Keegan, N. M.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Moving beyond PSA: Identifying the optimal diagnostic strategy to assess prostate cancer risk
    Meeting Abstract

    Cheung, D.; Magee, D. E.; Stonier, T.; Briggs, A.; Ferket, B.; Finelli, A.; Kulkarni, G. S.; Vickers, A.; Carlsson, S.; Eastham, J.
    European Urology (2022)

    Fulltext@MSK | Save
  • Inherited TP53 variants and risk of prostate cancer
    Journal Article

    Maxwell, K. N.; Cheng, H. H.; Powers, J.; Gulati, R.; Ledet, E. M.; Morrison, C.; Le, A.; Hausler, R.; Stopfer, J.; Hyman, S.; more...
    European Urology (2022)

    Fulltext@MSK | Save
  • Neutrophil-to-lymphocyte ratio in unclassified renal cell carcinoma is associated with clinical outcome and varies between genomic subgroups
    Meeting Abstract

    Marcon, J.; Di Natale, R. G.; Weng, S.; Ghanaat, M.; Silagy, A. W.; Mano, R.; Blum, K. A.; Attalla, K.; Reznik, E.; Carlo, M. I.; more...
    European Urology (2021)

    Fulltext@MSK | Save
  • The clinicopathologic and molecular landscape of clear cell papillary renal cell carcinoma: Implications in diagnosis and management
    Journal Article

    Weng, S.; DiNatale, R. G.; Silagy, A.; Mano, R.; Attalla, K.; Kashani, M.; Weiss, K.; Benfante, N. E.; Winer, A. G.; Coleman, J. A.; more...
    European Urology (2021)

    Fulltext@MSK | Save
  • Efficacy of PARP inhibition in metastatic castration-resistant prostate cancer is very different with non-BRCA DNA repair alterations: Reconstructing prespecified endpoints for cohort B from the phase 3 PROfound trial of olaparib
    Research Letter

    Stopsack, K. H.
    European Urology (2021)

    Fulltext@MSK | Save
  • Statins and prostate cancer: Bias, precision medicine, or population health?
    Editorial

    Stopsack, K. H.
    European Urology (2021)

    Fulltext@MSK | Save
  • Reply to Johann S. de Bono, Maha Hussain, and Jinyu Kang's letter to the editor re: Konrad H. Stopsack. Efficacy of PARP inhibition in metastatic castration-resistant prostate cancer is very different with non-BRCA DNA repair alterations: Reconstructing prespecified endpoints for cohort B from the phase 3 PROfound trial of olaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.09.024
    Correspondence

    Stopsack, K. H.
    European Urology (2021)

    Fulltext@MSK | Save